Clinical trial Recruiting at 1 site Observational Ages 18 and up

Awareness of heart disease risk factors and personal risk after a prior cardiovascular event

Official title: Awareness of Risk Factors and Perception of Cardiovascular Risk in Secondary Prevention: A Comparison Between Women and Men

Run by Istituti Clinici Scientifici Maugeri SpA · NCT07521436 · Data updated 2026-11-12

This survey will see if adults with prior atherosclerotic cardiovascular disease understand general and sex-specific risk factors and how at risk they feel of future events.

More Cardiovascular Disease trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorIstituti Clinici Scientifici Maugeri SpA
Academic / other
Locations1 site (Milan)
StatusRecruiting
StartedApril 10, 2026
Main results expectedJanuary 10, 2027
Study endsJanuary 10, 2027
Registry record updatedApril 29, 2026
Trial IDNCT07521436 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older with documented atherosclerotic cardiovascular disease (ischemic heart disease, cerebrovascular atherosclerotic disease, peripheral arterial disease, or atherosclerotic aortic disease) who can give informed consent are eligible.

Probably not a fit

People without established atherosclerotic cardiovascular disease, those with non-qualifying cerebrovascular events (e.g., primary intracerebral hemorrhage), or those unable to consent are not eligible and will not directly benefit from this survey.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational survey enrolling adults with established atherosclerotic cardiovascular disease to measure knowledge of general and sex/gender-specific risk factors and perceived risk of recurrent events. Participants complete questionnaires about their awareness of risk factors (including sex-specific conditions) and their perception of future cardiovascular risk. The study compares responses between women and men and examines whether having had a prior event is associated with changes in knowledge or risk perception. No medical or behavioral interventions are provided as part of the project.

Why it matters

Potential benefit: If gaps in knowledge or risk perception are identified, the findings could guide targeted education and follow-up strategies to improve prevention and adherence.

How similar studies have gone: Previous studies in primary prevention have shown low awareness of cardiovascular risk—especially among women—but there are limited or no data specifically focused on awareness and risk perception in secondary prevention, making this a novel, gap-filling effort.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

* Male or female participants aged ≥ 18 years at the time of signing informed consent.
* Individuals with atherosclerotic cardiovascular disease (ASCVD), defined as at least one of the following:
* Ischemic heart disease (e.g., documented myocardial infarction, percutaneous coronary intervention, coronary artery bypass grafting, or ≥50% coronary stenosis in at least two coronary territories);
* Cerebrovascular disease (e.g., documented ischemic stroke; transient ischemic attack, primary intracerebral hemorrhage, and subarachnoid hemorrhage are not qualifying conditions; carotid stenting or endarterectomy);
* Peripheral arterial disease (e.g., peripheral arterial intervention, stent placement, surgical revascularization, lower limb amputation due to obstructive disease, or intermittent claudication with ABI \<0.90 in the past 12 months);
* Atherosclerotic aortic disease (e.g., abdominal or descending thoracic aortic aneurysm).
* Signed informed consent.

Exclusion Criteria:

* Inability or difficulty in completing the questionnaires in Italian and/or functional illiteracy.
* History of or current severe psychiatric disorder that could compromise the reliability of questionnaire responses.
* Refusal or withdrawal of informed consent.

Where it's running

  • Istituti Clinici Scientifici IRCCS Maugeri
    Milan, Italy
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.